Search results for "228"

showing 10 items of 834 documents

The Burden of Pediatric Asthma

2018

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental factors (microbial exposure, exposure to passive smoking and air pollution), seemed to contribute to this trend. The increased prevalence observed in metropolitan areas with respect to rural ones and, overall, in industrialized countries, highlighted the role of air pollution in asthma inception. Asthma accounts for 1.1% of the overall global estimate of "Disability-adjusted life years" (DALYs)/100…

medicine.medical_specialtyPassive smokingTotal costMini ReviewprevalencemorbidityDiseasemedicine.disease_causePediatricsburden03 medical and health sciencesIndirect costs0302 clinical medicineQuality of life (healthcare)childrenEnvironmental healthEpidemiologycostMedicine030212 general & internal medicineAsthmabusiness.industrylcsh:RJ1-570lcsh:Pediatricsasthmamedicine.diseasemortality030228 respiratory systemPediatrics Perinatology and Child HealthepidemiologybusinessDeveloped countryFrontiers in Pediatrics
researchProduct

Metabolomics of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome : response to Maniscalco and Motta

2016

We appreciate Maniscalco and Motta’s comments on our recently published article “Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome” (Zabek et al. 2015) and we are grateful for the opportunity to clarify a number of points from our work. We are glad that the authors appreciated our data analysis and interpretation. Fusion of metabolomic data is an outstanding tool for a comprehensive description of patient’s phenotype that combines metabolic profiles acquired in different domains. Such an integrative approach is highly valued in the so-called ‘breathomics’ (Smolinska et a…

medicine.medical_specialtyPathologyEndocrinology Diabetes and MetabolismClinical BiochemistryDisease01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicineblood analysismedicineExhaled breath condensatebreath analysisIntensive care medicineLetter to the EditorPathologicalCOPDbusiness.industry010401 analytical chemistryOverlap syndromemedicine.diseaseObesity0104 chemical sciencesClinical trialObstructive sleep apnea030228 respiratory systembusiness
researchProduct

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.

2016

Abstract Background Hereditary angioedema (HAE) is a rare disease characterized by C1-esterase inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema, which can be life-threatening if they occur in the upper airway. No head-to-head comparisons of different treatment options for acute HAE attacks are available. Because immediate symptom relief is critical for potentially life-threatening laryngeal attacks, it is important to determine the treatment option that provides optimal treatment response. Objective Review and compare data from clinical studies that evaluated the efficacy and safety of treatments for laryngeal HAE attacks. Methods We conducted an indirect comparis…

medicine.medical_specialtyPathologyefficacyLaryngeal Diseases03 medical and health sciencesEcallantidechemistry.chemical_compound0302 clinical medicineSymptom reliefIcatibantInternal medicinemedicineHumans030212 general & internal medicineProspective cohort studyC1 esterase inhibitor deficiencybusiness.industryHAEAngioedemas Hereditarymedicine.diseaselaryngealTreatment Outcome030228 respiratory systemchemistryHereditary angioedemaEmergency MedicineC1-INHre-dosingbusinessAirwayComplement C1 Inhibitor Proteinmedicine.drugRare diseaseThe Journal of emergency medicine
researchProduct

Variability in recording and scoring of respiratory events during sleep in Europe: a need for uniform standards.

2015

Abstract: Uniform standards for the recording and scoring of respiratory events during sleep are lacking in Europe, although many centres follow the published recommendations of the American Academy of Sleep Medicine. The aim of this study was to assess the practice for the diagnosis of sleep-disordered breathing throughout Europe. A specially developed questionnaire was sent to representatives of the 31 national sleep societies in the Assembly of National Sleep Societies of the European Sleep Research Society, and a total of 29 countries completed the questionnaire. Polysomnography was considered the primary diagnostic method for sleep apnea diagnosis in 10 (34.5%), whereas polygraphy was …

medicine.medical_specialtyPediatricsCognitive NeurosciencePolysomnographyAlternative medicinePolysomnographySleep medicine03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineSleep Apnea SyndromesSurveys and QuestionnairesmedicineHumansSocieties MedicalSleep Medicine Specialtymedicine.diagnostic_testbusiness.industryRespirationApneaSleep apneaGeneral Medicinemedicine.diseaseObstructive sleep apneaEurope030228 respiratory systemFamily medicineHuman medicineSleep (system call)medicine.symptombusinessSleepHypopnea030217 neurology & neurosurgeryJournal of sleep research
researchProduct

Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (…

2016

Background: RES reduced exacerbation frequency and improved lung function and asthma control in pts with inadequately controlled asthma and elevated blood eosinophils (EOS) in two PBO-controlled, phase 3 trials (Castro et al. Lancet Resp Med 2015). Aims/objectives: To determine the efficacy of RES in asthma pts stratified by GINA Step 4 (G4) and Step 5 (G5) categories of asthma severity. Methods: Pooled data from two 52-week, PBO-controlled trials of RES (3mg/kg IV Q4W) in pts with inadequately controlled asthma and blood EOS ≥400/µL on inhaled corticosteroid (ICS) ± another controller; primary results have been reported. Current analysis includes pts stratified by G4 (medium/high-dose ICS …

medicine.medical_specialtyPediatricsExacerbationbusiness.industrymedicine.drug_classEosinophilic asthmaPlaceboRate ratiomedicine.diseaserespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemReslizumabInternal medicineAsthma controlMedicineCorticosteroid030212 general & internal medicinebusinessmedicine.drugAsthma5.1 Airway Pharmacology and Treatment
researchProduct

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

2016

ABSTRACT Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy. Methods: A Markov model was adapted to the Italian setting to estimate the incremental cost-effectiveness ratio (ICER) of bedaquiline plus BR (BBR) versus BR in the treatment of MDR-TB and XDR-TB over 10 years, from both the National Health Service (NHS) and societal perspective. Cost-effectiveness was evaluated in terms of life-years gained (LYG). Clinical data were sourced from trials; resource consumption for compared treatments was modelled according to advice from an expert c…

medicine.medical_specialtyPediatricsTuberculosisCost effectivenessBedaquilinelcsh:Business03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSocietal perspectivemedicineOriginal Research Article030212 general & internal medicineResource consumptionSensitivity analysescost-effectivenessDisease treatmenthealth care economics and organizationsbusiness.industrylcsh:Public aspects of medicinelcsh:RA1-1270medicine.diseaseNational health serviceMDR tuberculosis030228 respiratory systemchemistryItalyEmergency medicineXDR tuberculosisOriginal ArticleBedaquilinebusinesslcsh:HF5001-6182Journal of Market Access & Health Policy
researchProduct

Papel del médico de familia en el diagnóstico concomitante de mieloma y amiloidosis primaria en una misma paciente. Caso clínico

2018

Multiple Myeloma is a myeloproliferative disorder of plasma cells, which may be complicated with secondary amyloidosis. We report a 48 year old woman consulting to primary care for weight loss and malaise. An initial laboratory study revealed a hypogammaglobulinemia with a monoclonal component and lambda light chains. These results motivated her derivation to hematology: her serum calcium was 11.8 mg/dl, immunofluorescence showed a monoclonal component of lambda chains and urine Bence-Jones protein was positive. A bone marrow biopsy confirmed plasma cell infiltration. A Congo-red stain of a rectal biopsy was positive. The patient was treated with thalidomide, bortezomid and dexamethasone.

medicine.medical_specialtyPlasma CellsImmunofluorescenceGastroenterologyHypogammaglobulinemia03 medical and health sciences0302 clinical medicineInternal medicineBiopsymedicine030212 general & internal medicineMelanomaDexamethasoneMultiple myelomaHematologymedicine.diagnostic_testbusiness.industryCongo RedAmyloidosisGeneral Medicinemedicine.diseaseThalidomidemedicine.anatomical_structure030228 respiratory systemBone marrowMultiple MyelomabusinessMetges de famíliamedicine.drug
researchProduct

Longitudinal Asthma Patterns in Italian Adult General Population Samples: Host and Environmental Risk Factors.

2020

Background: Asthma patterns are not well established in epidemiological studies. Aim: To assess asthma patterns and risk factors in an adult general population sample. Methods: In total, 452 individuals reporting asthma symptoms/diagnosis in previous surveys participated in the AGAVE survey (2011–2014). Latent transition analysis (LTA) was performed to detect baseline and 12-month follow-up asthma phenotypes and longitudinal patterns. Risk factors associated with longitudinal patterns were assessed through multinomial logistic regression. Results: LTA detected four longitudinal patterns: persistent asthma diagnosis with symptoms, 27.2%

medicine.medical_specialtyPopulationlcsh:MedicinecomorbiditiesArticle03 medical and health sciences0302 clinical medicineEnvironmental riskInternal medicineEpidemiologymedicine030212 general & internal medicineeducationAsthmaMultinomial logistic regressionvehicular trafficeducation.field_of_studybusiness.industrylcsh:RAsthma symptomslatent transition analysisGeneral Medicinecohortasthmamedicine.diseaserespiratory tract diseases030228 respiratory systemsmokeasthma; epidemiology; cohort; latent transition analysis; comorbidities; smoke; vehicular trafficCohortLatent transition analysisepidemiologybusinessJournal of clinical medicine
researchProduct

Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control

2019

Background Recurrent angioedema (RA) is an important clinical problem in routine care and emergency medicine. As of recently, the only validated tools to specifically assess disease status in patients with RA were diary-type activity assessments and angioedema-related quality-of-life questionnaires. Although these tools are particularly helpful in clinical studies, they were not designed to determine disease control or to guide treatment decisions. To close this gap, the Angioedema Control Test (AECT) was published recently. Objective To test the AECT for its validity and reliability, and to identify a cutoff value to aid treatment decisions. Methods Two AECT versions with a recall period o…

medicine.medical_specialtyPsychometricsIntraclass correlationValidity03 medical and health sciences0302 clinical medicineCronbach's alphaSurveys and QuestionnairesmedicineHumansImmunology and AllergyPatient Reported Outcome Measures030212 general & internal medicineAngioedemaAngioedemabusiness.industryReproducibility of ResultsDermatology Life Quality Indexmedicine.disease030228 respiratory systemConvergent validityHereditary angioedemaQuality of LifePhysical therapyPatient-reported outcomemedicine.symptombusinessThe Journal of Allergy and Clinical Immunology: In Practice
researchProduct

International psychometric validation of the Living with Chronic Illness Scale in Spanish-speaking patients with chronic obstructive pulmonary disease

2021

Objectives To validate the Living with Chronic Illness (LW-CI) Scale in patients with chronic obstructive pulmonary disease (COPD). Design Observational, cross-sectional validation study with retest. Acceptability, reliability, precision and construct validity were tested. Setting The study took place in primary and secondary specialised units of public and private hospitals of Spain and Colombia. Participants The study included 612 patients with COPD assessed from May 2018 to May 2019. A consecutive cases sampling was done. Inclusion criteria included: (A) patients with a diagnosis of COPD; (B) native Spanish speaking; (C) able to read and understand questionnaires; and (D) able to provide…

medicine.medical_specialtyPsychometricsMedicinaIntraclass correlationPopulationNursingColombiaquality in health care03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineCronbach's alphaQuality of lifeInformed consentSurveys and QuestionnairesmedicineChronic airways diseaseHumans030212 general & internal medicine1506educationCOPDeducation.field_of_studybusiness.industryadult pathologyRConstruct validityReproducibility of ResultsGeneral Medicinemedicine.diseaseCross-Sectional Studies030228 respiratory systemSpainchronic airways diseaseChronic DiseasePhysical therapyQuality in health careQuality of LifeAdult pathologyMedicineObservational study1715business
researchProduct